Michael P. Dorsch, Jessica R. Golbus, Rachel Stevens, Brad Trumpower, Tanima Basu, Evan Luff, Kimberly Warden, Michael Giacalone, Sarah Bailey, Gabriella V. Rubick, Sonali Mishra, Predrag Klasnja, Mark W. Newman, Lesli E. Skolarus, Brahmajee K. Nallamothu
{"title":"体育活动和饮食及时的适应性干预降低血压:一项随机对照试验","authors":"Michael P. Dorsch, Jessica R. Golbus, Rachel Stevens, Brad Trumpower, Tanima Basu, Evan Luff, Kimberly Warden, Michael Giacalone, Sarah Bailey, Gabriella V. Rubick, Sonali Mishra, Predrag Klasnja, Mark W. Newman, Lesli E. Skolarus, Brahmajee K. Nallamothu","doi":"10.1038/s41746-025-01844-3","DOIUrl":null,"url":null,"abstract":"<p>Mobile health interventions for behavioral change require large-scale studies to ensure their clinical benefits. We conducted a randomized controlled trial of patients with hypertension to assess the myBPmyLife application in promoting physical activity and lower-sodium foods to lower systolic blood pressure (SBP). 602 participants were randomly assigned to either a control group or an intervention group that received the myBPmyLife application. For the primary outcome, change in SBP over 6 months was −5.2 mmHg in the intervention and −5.7 mmHg in the control group (<i>p</i> = 0.76). For secondary outcomes, the intervention group increased their daily step count by 170 steps, while the control group decreased by 319 steps (<i>p</i> = 0.040). Sodium intake decreased by 1145 mg in the intervention and 860 mg in the control group (<i>p</i> = 0.002). The myBPmyLife application did not reduce SBP over 6 months in hypertension patients despite increasing step counts and lowering sodium intake. <b>ClinicalTrials.gov registration</b>: NCT05154929, 12/2021</p>","PeriodicalId":19349,"journal":{"name":"NPJ Digital Medicine","volume":"23 1","pages":""},"PeriodicalIF":15.1000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Physical activity and diet just-in-time adaptive intervention to reduce blood pressure: a randomized controlled trial\",\"authors\":\"Michael P. Dorsch, Jessica R. Golbus, Rachel Stevens, Brad Trumpower, Tanima Basu, Evan Luff, Kimberly Warden, Michael Giacalone, Sarah Bailey, Gabriella V. Rubick, Sonali Mishra, Predrag Klasnja, Mark W. Newman, Lesli E. Skolarus, Brahmajee K. Nallamothu\",\"doi\":\"10.1038/s41746-025-01844-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Mobile health interventions for behavioral change require large-scale studies to ensure their clinical benefits. We conducted a randomized controlled trial of patients with hypertension to assess the myBPmyLife application in promoting physical activity and lower-sodium foods to lower systolic blood pressure (SBP). 602 participants were randomly assigned to either a control group or an intervention group that received the myBPmyLife application. For the primary outcome, change in SBP over 6 months was −5.2 mmHg in the intervention and −5.7 mmHg in the control group (<i>p</i> = 0.76). For secondary outcomes, the intervention group increased their daily step count by 170 steps, while the control group decreased by 319 steps (<i>p</i> = 0.040). Sodium intake decreased by 1145 mg in the intervention and 860 mg in the control group (<i>p</i> = 0.002). The myBPmyLife application did not reduce SBP over 6 months in hypertension patients despite increasing step counts and lowering sodium intake. <b>ClinicalTrials.gov registration</b>: NCT05154929, 12/2021</p>\",\"PeriodicalId\":19349,\"journal\":{\"name\":\"NPJ Digital Medicine\",\"volume\":\"23 1\",\"pages\":\"\"},\"PeriodicalIF\":15.1000,\"publicationDate\":\"2025-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Digital Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41746-025-01844-3\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Digital Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41746-025-01844-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Physical activity and diet just-in-time adaptive intervention to reduce blood pressure: a randomized controlled trial
Mobile health interventions for behavioral change require large-scale studies to ensure their clinical benefits. We conducted a randomized controlled trial of patients with hypertension to assess the myBPmyLife application in promoting physical activity and lower-sodium foods to lower systolic blood pressure (SBP). 602 participants were randomly assigned to either a control group or an intervention group that received the myBPmyLife application. For the primary outcome, change in SBP over 6 months was −5.2 mmHg in the intervention and −5.7 mmHg in the control group (p = 0.76). For secondary outcomes, the intervention group increased their daily step count by 170 steps, while the control group decreased by 319 steps (p = 0.040). Sodium intake decreased by 1145 mg in the intervention and 860 mg in the control group (p = 0.002). The myBPmyLife application did not reduce SBP over 6 months in hypertension patients despite increasing step counts and lowering sodium intake. ClinicalTrials.gov registration: NCT05154929, 12/2021
期刊介绍:
npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics.
The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.